PureTech Health plc (OTCMKTS:PTCHF – Get Free Report)’s share price fell 4.2% on Monday . The stock traded as low as $1.53 and last traded at $1.53. 2,000 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 38,795 shares. The stock had previously closed at $1.5970.
PureTech Health Stock Performance
The firm has a 50 day simple moving average of $1.70 and a 200-day simple moving average of $1.69.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Read More
- Five stocks we like better than PureTech Health
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
